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Abstract
Background: Several shared common gene networks participate in development of interstinal ganglia and also
nephron formation; the glial cell line-derived neurotrophic factor/Ret/glial cell line-derived neurotrophic factor
receptor gene network is particularly important.
Case presentation: We encountered a patient with total colonic aganglionosis as well as right renal agenesis and
oligomeganephronia. Gene analysis in this patient disclosed a heterozygous p.S811F mutation was in Ret gene
exon 14, resulting in a substitution of phenylalanine for serine. The large side chain of phenylalanine obstructed the
opening of the hydrophobic pocket of the Ret molecule causing interference with its interaction with adenosine
triphosphate and consequent marked reduction in its enzyme activity. This could account for our patient's severe
intestinal disease and renal dysplasia. We know of no previous reports of concomitant Hirschsprung’s disease and
oligomeganephronia.
Conclusions: The patient's overall illness could be considered a novel Ret gene mutation syndrome.
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Background
Oligomeganephronia (OMN) is a type of hypoplastic
kidney that most often represents congenital non-familial
renal dysplasia [1]. Histopathologically, the number of
nephrons per unit area is reduced, while those nephrons
present show both glomerular and tubular enlargement.
Unfavorable perinatal conditions such as prematurity, low
birth weight, advanced maternal age, and pregnancy-
induced hypertension have been reported to accompany
development of OMN [1]. However, OMN can occur in
the absence of such perinatal insults, arising instead from
mutations affecting genes including PAX2 involved in kid-
ney development [2, 3]. PAX2, encodes paired box gene 2,
is a transcription factors expressed in nephric duct and
metanephric mesenchyme and regulate the glial cell
line-derived neurotrophic factor (GDNF) and/or Ret
expression in the developing kidney [2]. In early phase
of kidney development, the receptor of GDNF, Ret
gene, and glial cell line-derived neurotrophic factor re-
ceptor (GFRα1) all are expressed throughout the region
of the Wolffian duct where they take part in nephron
formation under the control of GDNF [4].
In Hirschsprung’s disease (HSCR), the nerve network
controlling intestinal movement is congenitally absent in
the rectum and lower colon, precluding normal peristalsis
and causing intestinal enlargement [5]. In addition to intes-
tinal lesions, concomitant congenital anomalies of other or-
gans can occur in association with HSCR, solitary kidney
and renal dysplasia are among these additional disorders
[6]. Association of HSCR with abnormality of the GDNF/
GFRα1/Ret gene network also has been reported [7].
We encountered a patient with total-colonic aganglio-
nosis who also had right renal agenesis and OMN.
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Case presentation
A girl, currently 11 years old, was born at 40 weeks and
3 days of gestation. Birth weight was 3148 g (+0.4 SD,
relative to the mean). No known adverse perinatal con-
dition was present. She was hospitalized for abdominal
distention and bile-stained vomiting after birth. Emer-
gency operation was done due to intestinal perforation.
Diagnosed with severe total-colonic aganglionosis, she
underwent total colectomy except partial jejunum and
performed jejunostomy (Fig. 1a), resulting in short bowel
syndrome needed permanent ostomy and treated con-
tinuously with complete intravenous nutrition. Right
renal agenesis also was detected by abdominal ultrasonog-
raphy after birth (Fig. 1b). Albuminuria and macroscopic
hematuria appeared at about 10 years of age; urinary find-
ings repeatedly worsened on association with upper re-
spiratory infections. She therefore was admitted for a renal
biopsy. Family history and past medical history were
unrevealing.
On physical examination on admission, height was
143.8 cm (-0.2 SD); body weight, 33.8 kg (-0.6 SD); and
blood pressure, 111/72 mmHg. No abnormality was noted
concerning psychomotor development, nor did she show
any neurologic or neuromascular abnormality. On urinaly-
sis, urine specific gravity was 1.010, and pH was 7.5. By
dipstick testing, urinary protein was 2+, and microscopic
hematuria was present (3+). Microscopically, urinary red
blood cell count was 50 to 99/high-power field (HPF); and
white blood cell count, 1 to 4/HPF. Urinary protein level
was 1.09 g/day; β2-microglobulin was 656 μg/day. Blood
urea nitrogen was 29 mg/dL; serum creatinine, 1.09 mg/
dL; creatinine clearance, 36.8 mL/min/1.73 m2; and blood
cystatin C, 1.45 mg/L (normal range, 0.53 to 0.95),
showing renal dysfunction. No anemia or electrolyte
abnormality was detected.
Histologic findings in the renal biopsy specimen are
shown in Fig. 1c and d. Four glomeruli were present.
Glomeruli and renal tubules were enlarged; maximum
glomerular diameter was 189.17 μm (normal range, 100
to 130), mean glomerular area was 23019 μm2 (normal
range, 3000 to 5000) (Fig. 1c), and number of glomeruli
per unit area was 0.96/μm2 (normal range, >5) (Fig. 1d).
All of these features are characteristic of OMN. No de-
position of immunoglobulin or complement was evident
in glomeruli.
Genetic analysis
Genomic DNA was extracted from peripheral blood leuko-
cytes according to the standard protocols and performed
direct sequencing by Takara Bio technology (Shiga, Japan).
On analysis of GDNF/GFRα1/Ret genes, a heterozygous
p.S811F mutation was detected in Ret gene exon 14
(Fig. 2a), but 1476A which is associated with small kidneys
in neonates [8], was not present at position rs800, 860 of
Fig. 1 Findings in the large intestine and kidney in the present patient. Total-colon HSCR (a) and right renal agenesis (b) were present. On
histologic examination of the kidney, very few glomeruli (0.96/μm2) were present, and glomeruli and renal tubules were enlarged (c Periodic
acid-Schiff stain, x400 and d Masson trichrome stain, x100)
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the Ret gene. Instead, the nucleotide at 1476 was G (Fig. 2b).
No mutation was detected in the GDNF or PAX2 gene.
Molecular structure analysis
The X-ray crystallographic structure of the RET tyrosine
kinase domain-AMP complex [9] places Ser811 at the
opening of the adenosine triphosphate (ATP) binding
pocket, as shown in Fig. 2c. This hydrophobic pocket
has been used as a target to accomplish chemical inhibition
of RET kinase activity. In our patient's S811F mutation, the
enzyme activity of RET might well be decreased, consider-
ing that ATP binding in the pocket could be obstructed by
the bulky side chain of Phe811 at the opening (shown in
Fig. 2d).
Discussion
Various non-gastrointestinal disorders occur in HSCR
patients, including congenital urinary tract malformations
such as polycystic kidney, kidney dysplasia, vesicoureteral
reflex, hydronephrosis, double ureter, and horseshoe
kidney. One or more of these is evident in 20 % to 25 %
of HSCR patients [6, 10].
No ganglia can be identified in the intestinal wall distal
to the stomach in mice with a complete deficit of GDNF,
GFRα1, or Ret [11]. This phenotype is similar to human
HSCR with regard to lack of intestinal ganglia, but such
extensive absence is rare in humans. In many patients,
these ganglia are absent only in the lower large intestine.
Importantly, development or extension of the ureteral
bud does not occur in mice whose genes responsible for
signal transmission via the GDNF-Ret/Gfrα1 system
have been deleted [4, 12].
In Ret-deficient mice, inactivation of Ret in the late
fetal period leads to absence of neural components in
the lower large intestine, as also seen with GFRα1 de-
fects, implicating reduced Ret gene expression in HSCR
[13]. In mice with a lowered Ret gene expression, no ab-
normalities developed in the intestine or other organs in
heterozygous mice whose Ret expression was decreased
to 50 %. In contrast, mice whose expression was lowered
to 30 %, lacked intestinal wall ganglia in distal colorectal
segments; however no abnormality was noted in kidney
development [13]. These findings suggest that the
p.S811F mutation detected in exon 14 in our patient
caused marked inhibition of Ret molecule expression
or enzyme activity. We therefore analyzed the molecular
structure of the Ret gene. When phenylalanine is
substituted for serine, the large side chain of phenylalanine
Fig. 2 Ret gene analysis (a and b) and molecular models of the ATP binding site in the RET tyrosine kinase domain as well as a S811F mutant
(c and d). In exon 14, heterozygous substitution mutation from TCC to TTC, changing serine to phenylalanine, was detected (p.S811F) (a, indicated by
arrow), while the nucleotide at 1476 position was G (b, indicated by arrow). A molecular model of the ATP-binding site according to X-ray
crystallography of the RET tyrosine kinase domain-AMP complex (Protein Data Bank; 2IVT) is shown in (c) 3-dimentionally. AMP and Ser811 respectively
are represented by green and light blue spheres with some residues surrounding AMP were described by white rods in this molecular cartoon. Oxygen
and nitrogen atoms are colored red and blue, respectively. An S811F mutant model was constructed based on the structure above, also is shown (d).
Phe811 is depicted in yellow. Molecular modeling operations including display residue substitution, and structural optimization were performed using
MOE 2014.09 software (Chemical Computing Group., Montreal, Canada)
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blocks the opening of the hydrophobic pocket of the Ret
molecule, which may interfere with the interaction of the
Ret molecule with adenosine triphosphate, markedly
reducing enzyme activity that normally would prevent
development of HSCR involving the entire colon, as
well as right renal agenesis. Previously reported Ret
gene mutations associated with total colonic aganglio-
nosis, similar to our case, typically have been deletions
or frameshifts, such as N302EfsX53, K549_G550delD,
V636fsX1D, K549_G550delD, and V145GD [14]. To our
knowledge, no point mutation such as the one in our
patient, has been reported to cause total colonic aganglio-
nosis. Analysis of the specific mechanisms of pathogenesis
involving the p.S811F mutation is necessary.
Uesaka et al. [13] carried out an extensive search for
genes induced downstream from RET tyrosine kinase in
response to GDNF stimulation using a differential display
method; among the 14 genes obtained; that study identi-
fied a gene containing many zinc finger motifs at the C-
terminus and at the BTB/POZ domain in the N-terminus.
Antibodies prepared to investigate distribution of expres-
sion immunohistochemically confirmed that this gene is
specifically expressed in the ureteric bud during develop-
ment of the kidney, occurring in the RET-expressing re-
gion slightly later than the Ret expression. This suggests
that expression of the gene is induced by GDNF. When
those authors inhibited expression of this gene using anti-
sense oligonucleotides in kidney organ culture, ureteric
bud formation, for which the GDNF-Ret signal is essential,
was greatly inhibited. This gene was named GZF1, since a
GDNF-inducible gene with BTB/POZ domain and zinc
finger motifs that are highly expressed in ureteric bud of
the metanephric kidney; GZP1 gene is a crucial in kidney
development. Our patient's p.S811F mutation may have
influenced GZF1, located downstream of the GDNF/RET
signaling pathway [15].
Causes of urinary abnormality and decreased renal
function in our patient may involve renal pathophysiologic
derangements arising from excess glomerular filtration in
the left kidney as a result of right renal agenesis, as well as
the paucity of nephrons imposed by OMN. When renal
failure progresses, dialysis and kidney transplantation
would be considered, but her underlying HSCR with
short-bowel syndrome may complete these measures.
Conclusions
Here we report a patient with total-colonic aganglionosis
and concomitant right renal agenesis as well as OMN. To
our knowledge, no similar case including OMN has been
reported. Association of OMN with PAX2 gene mutations
aberration has been reported [3], but no mutation was de-
tected in GDNF or PAX2 in our patient. Therefore, the Ret
gene mutation is likeliest cause at OMN in this individual.
We consider this patient's overall disease to be a Ret gene
mutation syndrome.
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